Dydrogesterone for abnormal uterine bleeding in teens
Part of Women’s health & pregnancy clinical trials.
This trial tests if dydrogesterone, a hormone pill, can safely help teenagers with heavy or irregular periods. If you or your child have had unusual bleeding that isn't caused by pregnancy or other medical issues, this study may provide treatment options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a female aged 10 to 19, and your periods started at least 6 months ago.
- You have had irregular, long, or heavy periods in the last 3 months, like cycles shorter than 21 days or longer than 45 days, periods lasting more than 7 days, or a bleeding score over 100.
- Your guardian must sign a consent form, and you must agree to join the study.
- You need to have certain test results available, like a blood count, iron level, hormone tests, and a pelvic ultrasound.
- You cannot have a blood clotting disorder or take blood-thinning medication.
- You cannot have untreated thyroid or other hormone problems that cause abnormal bleeding, or severe kidney or liver issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether taking an oral progesterone-like medicine (dydrogesterone) during the “luteal phase” after a natural-cycle frozen embryo transfer can improve support for implantation. It may help couples who are using their own embryos in a natural (hormone-sparing) cycle after thawing.
This study tests whether different types of hormonal medication (such as pills or an intrauterine device) can help manage heavy periods in adolescents and young adults. The goal is to find what works best for reducing bleeding and improving quality of life.
This trial studies how a progestin hormone—given as an IUD or tablets—can help reduce heavy menstrual bleeding in people with certain bleeding-related conditions. It may help you by testing whether the treatment works and is practical for your situation.
This trial tests an investigational medication called BT-114143 for people with heavy menstrual bleeding (abnormal uterine bleeding). The goal is to see if it is safe and effective in reducing blood loss during periods.
This trial tests whether a GLP-1 receptor agonist can help improve irregular periods in teenage girls with type 1 diabetes. It's for girls aged 12 to 18 who have had their period for at least 2 years, use a continuous glucose monitor, and have higher blood sugar levels (HbA1c of 7% or more).
This trial is testing two medicines—calcium dobesilate and tranexamic acid—to see which is better at reducing heavy menstrual bleeding. If you join, you'll receive one of these treatments to help manage your symptoms.
Hear when a new Abnormal Uterine Bleeding (AUB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.